Dystroglycan is able to translocate to the nucleus in the androgen-independent prostate cell lines PC3 and DU145 (see supplementary figure 4 in reference13), demonstrating that dystroglycan translocation to the nucleus in prostate cancer cells is not necessarily part of the androgen response mechanism driven through the androgen receptor. This evidence concerns the gene DAG1 and prostate cancer.